Clinical Trials Logo

Biliary Tract Diseases clinical trials

View clinical trials related to Biliary Tract Diseases.

Filter by:

NCT ID: NCT03879720 Recruiting - Pancreatic Diseases Clinical Trials

Comparison of Standard and Endoscope Assisted Endotracheal Intubation

Start date: August 30, 2018
Phase: N/A
Study type: Interventional

Comparison of standard endotracheal intubation and endoscopist-facilitated endotracheal intubation

NCT ID: NCT03698266 Completed - ERCP Clinical Trials

Is Needle Knife Fistulotomy An Effective First Step Strategy For All ERCPs?

Start date: November 23, 2018
Phase: N/A
Study type: Interventional

Participants in this study will be undergoing a procedure called an endoscopic retrograde cholangiopancreatography (ERCP). This procedure is most commonly performed to help treat conditions affecting specific areas of the digestive system called the pancreas and bile ducts. Patients will consent to allow the study physician to access these areas of the digestive system by making a cut using a technique called a needle-knife fistulotomy. If the physician is unable to gain access through this method, they will make the cut using a technique called a sphincterotomy.

NCT ID: NCT03678480 Withdrawn - Clinical trials for Primary Sclerosing Cholangitis

A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)

Start date: March 1, 2021
Phase: Phase 2
Study type: Interventional

Randomized, double-blind, active-controlled, parallel-group study of HTD1801 in adolescents.

NCT ID: NCT03504293 Completed - Neoplasms Clinical Trials

The Diagnostic Value of Combinatory EUS and ERCP in Unclear Lesions

Start date: January 1, 2010
Phase:
Study type: Observational

ERCP with brush cytology has a poor to moderate accuracy in unclear biliary lesions. Endoscopic ultrasound (EUS) with fine needle aspiration (FNA) for cytology may override some of these shortcomings. The current prospective study, performed in a tertiary University center, aims to study the feasibility, the accuracy and the clinical value of combinatory ERCP and EUS in unclear biliary lesions.

NCT ID: NCT03190343 Active, not recruiting - Clinical trials for Biliary Tract Diseases

Assessment of Cholangio-pancreatoscopy for the Diagnosis and the Treatment of Biliary and Pancreatic Diseases

Start date: November 2016
Phase:
Study type: Observational [Patient Registry]

The biliary and pancreatic tumors are rare but the prognosis is pejorative. It was difficult to have histology of these tumors as the samples taken during ERCP were performed under " blind " radiology control. So the diagnostic accuracy was insufficient. The arrival of A new optic fiber endoscope used by only one operator had improved the diagnostic of bilio-pancreatic diseases. However this technology with optic fiber quickly had proved outdated for several reasons: poor manoeuvrability, perfectible optical vision, optical fibers fragility and cost. A new generation of endoscopes with digital vision appeared and would allow an increase in diagnostic accuracy related to better vision and manoeuvrability. The purpose of the study is to assess the interest of the cholangio pancreatoscopy performed with digital vision.

NCT ID: NCT03074708 Recruiting - Liver Diseases Clinical Trials

Application of 3D Visualization and 3D Printing in the Hepatobiliary and Pancreatic Surgery

Start date: March 2017
Phase: N/A
Study type: Interventional

Background:The aim of the study is to value the application of three-dimensional visualization and three-dimensional printing in the hepatobiliary and pancreatic surgery.Method:From January 2016 to December 2018,the clinical data of 200 patients with the hepatobiliary and pancreatic diseases will be collected.All the patients received abdominal CT scanning and 3D reconstruction. Then we used the 3D reconstruction model and the 3D printed model based on the 3D reconstruction model in the operation planning and the operation.The clinical data include operative time, intraoperative blood loss,and postoperative complications after surgery.

NCT ID: NCT02971579 Completed - Pancreatic Diseases Clinical Trials

A Register on the Quality of ERCP and Training of Endoscopists in Italy

REQUEST
Start date: September 2016
Phase:
Study type: Observational

This is a prospective observational longitudinal study Aim of the study is to collect information: - on the organization models of the Endoscopic Units performing ERCP in Italy - on the previous and/or ongoing training of the endoscopists performing ERCP - on the clinical characteristics of patients undergoing ERCP in Italy as well as on the outcome

NCT ID: NCT02584283 Completed - Liver Failure Clinical Trials

Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After Transplantation

DHOPE-DCD
Start date: January 2016
Phase: Phase 3
Study type: Interventional

Rationale: Recent publications report good results of controlled donation after circulatory death (DCD) Maastricht category III liver transplantation when strict donor-recipient matching is applied and ischemia times are kept to a minimum. However a major concern remains the high rate of biliary complications after transplantation of DCD livers. Non-anastomotic biliary strictures (NAS) occur in 29% of patients receiving a DCD graft whereas the incidence of NAS in recipients of donation after brain death (DBD) liver grafts is 11%. NAS are associated with higher morbidity and increased cost of liver transplantation. Injury to the biliary epithelium and the peribiliary vascular plexus occurring during donor warm ischemia and static cold storage (SCS) has been identified as a major risk factor for development of NAS. Machine perfusion has been proposed as an alternative strategy for organ preservation, offering the opportunity to improve the quality of the organ by providing oxygen to the graft. Experimental studies have shown that end-ischemic dual hypothermic oxygenated machine perfusion (DHOPE) helps liver grafts to recover from ischemia by restoring mitochondrial function. Moreover, DHOPE has been shown to provide better preservation of peribiliary vascular plexus of the bile ducts, which could be an important step forward in reducing the incidence of NAS after transplantation. Objective: To study the efficacy of end-ischemic DHOPE in reducing the incidence of NAS within six months after controlled DCD (Maastricht category III) liver transplantation. Study design: An international, multicenter, prospective, randomized, controlled, interventional, clinical trial with a two parallel arm approach (treatment/control). Study population: Adult patients (≥18 yrs old) undergoing a liver transplantation with a liver graft procured from a controlled DCD donor (Maastricht category III) with a body weight ≥40 kg. Intervention: In the intervention group liver grafts will be subjected to two hours of hypothermic, oxygenated perfusion at the end of SCS and before implantation. In the control group donor liver grafts will be preserved in accordance to standard practice by SCS only. Main study parameters/endpoints: The incidence and severity of symptomatic NAS as diagnosed by an Adjudication committee (who are blinded for the group assignment) by means of magnetic resonance cholangiopancreatography (MRCP).

NCT ID: NCT02524418 Recruiting - Clinical trials for Biliary Tract Disease

Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS

SPYDS
Start date: August 2015
Phase: N/A
Study type: Interventional

This is a prospective evaluation of the clinical utility of the new cholangioscopy platform SpyGlass DS. The aims of this study are to prospectively document the clinical utility and technical aspects of ERCP with cholangioscopy and/or pancreatoscopy in the diagnosis and management of pancreata-biliary disorders.

NCT ID: NCT02353286 Completed - Clinical trials for Biliary Tract Diseases

Endoscopic Treatment of Benign Biliary Strictures and Cystic Duct Leakages With a Novel Biodegradable Biliary Stent

Start date: May 2014
Phase: N/A
Study type: Interventional

Patients with either post-cholecystectomy bile leak or benign biliary stricture are recruited for endoscopic insertion of a biodegradable biliary stent. A follow-up of 12 months with repeated serum samples and magnetic resonance imaging is scheduled. The primary end points are feasibility of endoscopic insertion with the novel implantation device and stricture or leak resolution as well as clinical treatment success.